companydata.dkPharmyn ApS: Financial statements 2020
CVR: 37133892
Pharmyn ApS (CVR 37133892) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -20,104 and a net result of DKK -20,728 compared with DKK 0 the year before. Equity amounted to DKK 21,651. The solvency ratio was 18.9%.
- Gross Profit
- -20,104 kr.
- Profit/Loss
- -20,728 kr.
- Equity
- 21,651 kr.
- Total Assets
- 114,447 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -20 t. | -21 t. | 22 t. | 0 |
| 2019 | - | 108 | 0 | 42 t. | 1 |
| 2018 | - | 288 | 88 | 42 t. | 0 |
| 2017 | - | -4 t. | -4 t. | 42 t. | - |
How creditworthy is Pharmyn ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Pharmyn ApS has published its annual report for 2019. Gross profit came to DKK 108, and the net result was DKK 0.
About Pharmyn ApS
Pharmyn ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Henrik Lund Uth. The company is owned by Henrik Lund Uth. In 2025, the company reported a gross profit of DKK -12,457 and a net result of DKK -12,409 compared with DKK 6,701 the year before. Equity amounted to DKK 18,662.